Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen Lozenges for Acute Sore Throat Pain
NCT01535079Phase 2Completed
- Sponsor
- Pierre Fabre Laboratories
- Start
- Feb 2012
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial of ibuprofen in acute pharyngitis (5 arms), sponsored by Pierre Fabre Laboratories. Primary endpoint: Change from baseline of Sore Throat Pain Intensity Scale at 60 minutes. Started Feb 2012; status: completed.
02
Drugs
ibuprofen
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on NCT01535079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01535079.